Craniosynostosis, a condition where skull sutures fuse prematurely in children, can raise concerns about intracranial hypertension (ICH) – increased pressure within the skull. Traditionally, diagnosing ICH relies on invasive procedures. This review examines a promising new approach: handheld optical coherence tomography (OCT). Analyzing studies on handheld OCT use in children with craniosynostosis, we explore its feasibility, advantages, and potential role in improving diagnosis and patient care.
Craniosynostosis affects 1 in 2,000 newborns, often requiring surgery to correct skull shape and prevent complications. A significant concern is intracranial hypertension (ICH), which can damage the brain and vision if left untreated. Traditionally, diagnosing ICH involves invasive procedures like lumbar punctures or intracranial pressure monitoring. These methods are not ideal for young children, prompting the search for non-invasive alternatives.
Optical coherence tomography (OCT) is a revolutionary imaging technique that uses light to create detailed cross-sectional images of tissues. Recent advancements have led to the development of handheld OCT devices, making them more portable and user-friendly for pediatric applications. This review focuses on the feasibility of handheld OCT in diagnosing ICH in children with craniosynostosis.
Several studies have explored the use of handheld OCT in this context. These studies demonstrate promising results:
High Success Rates: Studies report successful image acquisition in a high percentage of children, exceeding 80% in some cases.
Feasibility for Young Children: Handheld OCT appears well-suited for young children, with good compliance and minimal discomfort.
Repeatability: Studies suggest good repeatability of OCT measurements, allowing for monitoring of pressure changes over time.
Handheld OCT offers several advantages over traditional methods for diagnosing ICH in children with craniosynostosis:
Non-invasive: Eliminates the need for needles or sedation, reducing risks and discomfort for children.
Quick and painless: OCT scans are completed in seconds, minimizing stress for patients.
Portable: Handheld devices allow for examinations at the bedside, improving accessibility.
Objective data: OCT provides quantitative measurements, aiding in diagnosis and monitoring.
While these initial studies are encouraging, further research is needed to fully establish handheld OCT as a standard diagnostic tool for ICH in children with craniosynostosis. Larger, multicenter trials are crucial to confirm its effectiveness and identify potential limitations. Additionally, exploring the correlation between OCT findings and other measures of ICH is important.
Handheld OCT holds immense potential for revolutionizing the diagnosis of ICH in children with craniosynostosis. This review highlights the feasibility, advantages, and future directions for this promising non-invasive technology. As research progresses, handheld OCT may become a valuable tool in improving early detection and management of ICH, leading to better outcomes for young patients.
1.
Common intracellular toxin could help fight leukemia
2.
CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma
3.
Scholastic performance is a key concern for young cancer patients, study finds
4.
AACR: American Association for Cancer Research
5.
Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven
1.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
2.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
3.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
4.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
5.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
5.
Advances in Modern Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation